Multiple myeloma: Clinical Practice Guidelines in Oncology™ Journal Article
| Authors: | Anderson, K. C.; Alsina, M.; Bensinger, W.; Biermann, J. S.; Chanan-Khan, A.; Comenzo, R. L.; De Castro, C. M.; Djulbegovic, B.; Farag, S.; Huff, C. A.; Meredith, R.; Schriber, J.; Shrieve, D.; Singhal, S.; Smith, M. R.; Stockerl-Goldstein, K.; Vose, J. M.; Weber, D.; Yahalom, J.; Yunus, F. |
| Article Title: | Multiple myeloma: Clinical Practice Guidelines in Oncology™ |
| Abstract: | Although multiple myeloma is sensitive to both chemotherapy and radiation therapy, it remains incurable. However, treatment algorithms (based on published data and clinical experience) can be developed to optimize therapy, which include not only therapy for the underlying disease but also supportive therapy to enhance quality of life. These guidelines prominently identify the clinical settings appropriate for treatment of patients on clinical research protocols. © Journal of the National Comprehensive Cancer Network. |
| Keywords: | cancer survival; treatment response; overall survival; fludarabine; lenalidomide; prednisone; thalidomide; allogeneic stem cell transplantation; clinical trial; neutropenia; salvage therapy; cisplatin; doxorubicin; interferon; placebo; cancer combination chemotherapy; monotherapy; antineoplastic agents; conference paper; cancer radiotherapy; radiation dose; combined modality therapy; rituximab; cancer staging; drug megadose; follow up; clinical practice; low drug dose; bortezomib; controlled clinical trial; multiple myeloma; etoposide; neuropathy; randomized controlled trial; peripheral neuropathy; c-reactive protein; combination chemotherapy; cytogenetics; immunomodulatory drugs; nccn clinical practice guidelines; primary amyloidosis; stem cell transplant; waldenström's monoclonal protein; alkylating agent; bisphosphonic acid derivative; calcitonin; cyclophosphamide; dexamethasone; furosemide; melphalan; steroid; vincristine; amyloidosis; autologous stem cell transplantation; bradycardia; deep vein thrombosis; hypercalcemia; plasmacytoma; plasmapheresis; practice guideline; stem cell transplantation; waldenstroem macroglobulinemia; rash; whole body radiation; cancer relapse; physical examination; blood cell count; m protein; hydration; zoledronic acid; cladribine; blood examination; osteopenia; pamidronic acid; waldenstrom macroglobulinemia; humans; human; proteosome inhibitor |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 5 |
| Issue: | 2 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2007-02-01 |
| Start Page: | 118 |
| End Page: | 147 |
| Language: | English |
| PUBMED: | 17335683 |
| PROVIDER: | scopus |
| DOI: | 10.6004/jnccn.2007.0014 |
| DOI/URL: | |
| Notes: | Conference Paper -- Export Date: 22 January 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work